ChromaDex Stock Quote CDXC - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

5.22

Bid

5.21

Ask

5.23

Volume

398,223

5.17 Day's Range 5.52

1.36 52 Week Range 7.9738

Market Cap

398.721M

Previous Close

5.27

Open

5.23

Last Trade

5.2358

Last Trade Time

15:02:13

Financial Volume

$ 2,134,380

VWAP

5.3598

Average Volume (3m)

1,397,256

Shares Outstanding

76,383,267

Dividend Yield

PE Ratio

-81.73

Earnings Per Share (EPS)

-0.06

Revenue

83.57M

Net Profit

-4.94M

ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship in... ChromaDex Corp is a bioscience company dedicated to healthy aging. The ChromaDex team is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex's patent portfolio. It delivers Niagen as the sole active ingredient in its consumer product namely, Tru Niagen which is available on Tru Niagen's website and through partnerships with retailers and distributors. Show more

Sector

Medicinal Chems,botanicl Pds

Industry

Medicinal Chems,botanicl Pds

Website

www.chromadex.com

Headquarters

Dover, Delaware, USA

Founded

ChromaDex Corporation is listed in the Medicinal Chems,botanicl Pds sector of the NASDAQ with ticker CDXC. The last closing price for ChromaDex was $5.27. Over the last year, ChromaDex shares have traded in a share price range of $ 1.36 to $ 7.9738.

ChromaDex currently has 76,383,267 shares outstanding. The market capitalization of ChromaDex is $402.54 million. ChromaDex has a price to earnings ratio (PE ratio) of -81.73.

ChromaDex to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

ChromaDex Corp. (NASDAQ: CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) with a focus on the science of healthy aging, today announced that it will participate in a...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category

ChromaDex Corp. (NASDAQ:CDXC) proudly announces its inclusion on the Inc. 2024 Best in Business list in the Health Products category. Inc.’s annual Best in Business Awards celebrate the...

Form 4 - Statement of changes in beneficial ownership of securities

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 8-K - Current report

ChromaDex’s Patented Nicotinamide Riboside (NR) Ingredient, Niagen®, Featured as the Hero Ingredient in Longevity.Technology’s Inaugural Longevity Supplement

The gold standard in NAD+ supplementation, Niagen® is a key ingredient for supporting cellular health and promoting healthy aging in Longevity.Technology’s new supplement ChromaDex Corp. (NASDAQ:...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.378	-6.75241157556	5.598	5.64	5.16	334586	5.37377978	CS
4	-0.82	-13.5761589404	6.04	6.23	5.16	477747	5.55547615	CS
12	1.72	49.1428571429	3.5	7.9738	3.39	1397256	6.15779865	CS
26	2.48	90.5109489051	2.74	7.9738	2.53	775303	5.60371085	CS
52	3.79	265.034965035	1.43	7.9738	1.36	554482	4.82681464	CS
156	2.07	65.7142857143	3.15	7.9738	1.15	351516	3.44668335	CS
260	0.59	12.7429805616	4.63	23.66	1.15	545531	8.08809507	CS

CDXC - Frequently Asked Questions (FAQ)

What is the current ChromaDex share price?

The current share price of ChromaDex is $ 5.22

How many ChromaDex shares are in issue?

ChromaDex has 76,383,267 shares in issue

What is the market cap of ChromaDex?

The market capitalisation of ChromaDex is USD 402.54M

What is the 1 year trading range for ChromaDex share price?

ChromaDex has traded in the range of $ 1.36 to $ 7.9738 during the past year

What is the PE ratio of ChromaDex?

The price to earnings ratio of ChromaDex is -81.73

What is the cash to sales ratio of ChromaDex?

The cash to sales ratio of ChromaDex is 4.83

What is the reporting currency for ChromaDex?

ChromaDex reports financial results in USD

What is the latest annual turnover for ChromaDex?

The latest annual turnover of ChromaDex is USD 83.57M

What is the latest annual profit for ChromaDex?

The latest annual profit of ChromaDex is USD -4.94M

What is the registered address of ChromaDex?

The registered address for ChromaDex is 838 WALKER ROAD, SUITE 21-2, DOVER, DELAWARE, 19904

What is the ChromaDex website address?

The website address for ChromaDex is www.chromadex.com

Which industry sector does ChromaDex operate in?

ChromaDex operates in the MEDICINAL CHEMS,BOTANICL PDS sector

Symbol	Price	Vol.
PHIOPhio Pharmaceuticals Corporation	$ 7.6627 (353.41%)	264.35M
SLRXSalarius Pharmaceuticals Inc	$ 3.9399 (151.75%)	113.17M
ATPCAgape ATP Corporation	$ 2.0604 (63.52%)	82.21M
VRMEVerifyMe Inc	$ 3.9501 (54.91%)	53.57M
XXII22nd Century Group Inc	$ 7.2151 (47.55%)	22.36M
EHGOEshallgo Inc	$ 1.2954 (-60.39%)	5.57M
HUBCWHub Cyber Security Ltd	$ 0.0161 (-46.33%)	262.63k
CMTLComtech Telecommunications Corporation	$ 2.2452 (-45.64%)	3.78M
LAESSEALSQ Corporation	$ 3.48 (-39.27%)	67.88M
SVMHSRIVARU Holding Ltd	$ 0.03775 (-38.92%)	159.6M
GCTKGlucoTrack Inc	$ 0.1371 (17.18%)	643.11M
PHIOPhio Pharmaceuticals Corporation	$ 7.6852 (354.75%)	264.36M
BHATBlue Hat Interactive Entertainment Technology	$ 0.0641 (-27.24%)	176.4M
SVMHSRIVARU Holding Ltd	$ 0.03775 (-38.92%)	159.6M
NVDANVIDIA Corporation	$ 132.02 (-2.86%)	157.9M

Symbol

Price

Vol.